跳至主要内容
临床试验/CTRI/2016/10/007381
CTRI/2016/10/007381尚未招募4 期

â??Therapeutic Drug Monitoring of Phenytoin,Carbamazepine and Sodium Valproate in Patientswith Epilepsy by High Performance LiquidChromatography (HPLC) in A Tertiary Health CareTeaching Hospital: A Prospective ObservationalStudyâ??

Department of Pharmacology Government Medical College Bhavnagar0 个研究点目标入组 105 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
105

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Patients of any age and both gender who are willing to give written inform consent.
  • In case of patients less than 18 years of age guardian must be there to provide written inform consent.
  • Patients on Anti-Epileptic treatment with Phenytoin, Carbamazepine or Sodium valproate and in combination therapy with any of these or other Anti-Epileptic drugs for six months or more.

排除标准

  • Patients on Anti-Epileptic Drugs for less than six months.
  • Patients on these drugs for indication other than Epilepsy.
  • Patients with history of hepatitis-B OR hepatitis-C
  • Patient who do not give consent.

研究者

发起方
Department of Pharmacology Government Medical College Bhavnagar

相似试验